{"transactions":[{"id":711839,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31222,"kind":"person","name":"Weigerstorfer Philippe","position":1,"cik":"0001751449","reported_name":"Weigerstorfer Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-07-10T00:47:51.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. Weigerstorfer for services performed on the Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest one third each on 7/9/2027, 7/9/2028 and 7/9/2029, or upon change of control."}],"balance_after":30001,"derivative":{"exercise_price":1.26,"expiration_date":"2036-07-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001683168-26-005423","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751449/000168316826005423/ownership.xml","form_type":"4"}},{"id":711743,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31186,"kind":"person","name":"Trombly Amy Moss","position":1,"cik":"0001384640","reported_name":"Trombly Amy Moss","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-07-10T00:47:38.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The RSUs were awarded and granted to Ms. Trombly for services performed."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest on the third anniversary of the grant date, or upon change of control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest on the third anniversary of the grant date, or upon change of control."}],"balance_after":52185,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001683168-26-005422","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316826005422/ownership.xml","form_type":"4"}},{"id":711759,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31191,"kind":"person","name":"MCLAUGHLIN JOHN","position":1,"cik":"0001203240","reported_name":"MCLAUGHLIN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-07-10T00:47:24.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. McLaughlin for services performed on the Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest one third each on 7/9/2027, 7/9/2028 and 7/9/2029, or upon change of control."}],"balance_after":30001,"derivative":{"exercise_price":1.26,"expiration_date":"2036-07-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001683168-26-005421","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203240/000168316826005421/ownership.xml","form_type":"4"}},{"id":711742,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31185,"kind":"person","name":"Jacoby Vanessa","position":1,"cik":"0002110126","reported_name":"Jacoby Vanessa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-07-10T00:47:11.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Ms. Jacoby for services performed on the Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest one third each on 7/9/2027, 7/9/2028 and 7/9/2029, or upon change of control."}],"balance_after":20000,"derivative":{"exercise_price":1.26,"expiration_date":"2036-07-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001683168-26-005420","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316826005420/ownership.xml","form_type":"4"}},{"id":711741,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31184,"kind":"person","name":"DVONCH JEROME J","position":1,"cik":"0001518735","reported_name":"DVONCH JEROME J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-07-10T00:46:55.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The RSUs were awarded and granted to Mr. Dvonch for services performed."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs on the third anniversary of the grant date, or upon change of control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs on the third anniversary of the grant date, or upon change of control."}],"balance_after":44391,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001683168-26-005419","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316826005419/ownership.xml","form_type":"4"}},{"id":711740,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31183,"kind":"person","name":"Dal Poggetto John","position":1,"cik":"0001791040","reported_name":"Dal Poggetto John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller"}}],"security":"Restricted Stock Units","published_at":"2026-07-10T00:46:42.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The RSUs were awarded and granted to Mr. Dal Poggetto for services performed."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest on the third anniversary of the grant date, or upon change of control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest on the third anniversary of the grant date, or upon change of control."}],"balance_after":32750,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001683168-26-005418","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316826005418/ownership.xml","form_type":"4"}},{"id":955239,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31222,"kind":"person","name":"Weigerstorfer Philippe","position":1,"cik":"0001751449","reported_name":"Weigerstorfer Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-01-02T22:25:11.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. Weigerstorfer for services performed on the Board of Directors as part of the Company's annual grant of stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest one third each on 1/2/2027, 1/2/2028 and 1/2/2029, or upon change of control."}],"balance_after":20001,"derivative":{"exercise_price":3.68,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001683168-26-000045","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751449/000168316826000045/ownership.xml","form_type":"4"}},{"id":954963,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31186,"kind":"person","name":"Trombly Amy Moss","position":1,"cik":"0001384640","reported_name":"Trombly Amy Moss","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-01-02T22:24:16.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The RSUs were awarded and granted to Ms. Trombly for services performed."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest on the third anniversary of the grant date, or upon change of control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest on the third anniversary of the grant date, or upon change of control."}],"balance_after":42185,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001683168-26-000042","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316826000042/ownership.xml","form_type":"4"}},{"id":955010,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31191,"kind":"person","name":"MCLAUGHLIN JOHN","position":1,"cik":"0001203240","reported_name":"MCLAUGHLIN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-01-02T22:22:56.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. McLaughlin for services performed on the Board of Directors as part of the Company's annual grant of stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest one third each on 1/2/2027, 1/2/2028 and 1/2/2029, or upon change of control."}],"balance_after":20001,"derivative":{"exercise_price":3.68,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001683168-26-000036","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203240/000168316826000036/ownership.xml","form_type":"4"}},{"id":954962,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31184,"kind":"person","name":"DVONCH JEROME J","position":1,"cik":"0001518735","reported_name":"DVONCH JEROME J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-01-02T22:22:03.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The RSUs were awarded and granted to Mr. Dvonch for services performed."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs on the third anniversary of the grant date, or upon change of control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs on the third anniversary of the grant date, or upon change of control."}],"balance_after":34391,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001683168-26-000032","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316826000032/ownership.xml","form_type":"4"}},{"id":954961,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31183,"kind":"person","name":"Dal Poggetto John","position":1,"cik":"0001791040","reported_name":"Dal Poggetto John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller"}}],"security":"Restricted Stock Units","published_at":"2026-01-02T22:21:22.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The RSUs were awarded and granted to Mr. Dal Poggetto for services performed."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest on the third anniversary of the grant date, or upon change of control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest on the third anniversary of the grant date, or upon change of control."}],"balance_after":25250,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001683168-26-000031","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316826000031/ownership.xml","form_type":"4"}},{"id":954959,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":70572,"kind":"person","name":"Birnbaum Jay E","position":1,"cik":"0001397470","reported_name":"Birnbaum Jay E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-01-02T22:20:29.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. Birnbaum for services performed on the Board of Directors as part of the Company's annual grant of stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest one third each on 1/2/2027, 1/2/2028 and 1/2/2029, or upon change of control."}],"balance_after":20001,"derivative":{"exercise_price":3.68,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001683168-26-000030","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316826000030/ownership.xml","form_type":"4"}},{"id":1104746,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":78266,"kind":"person","name":"Thornton Bruce","position":1,"cik":"0001383288","reported_name":"Thornton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP and COO"}}],"security":"Restricted Stock Units","published_at":"2025-06-20T21:00:10.000Z","date":"2025-06-19","kind":"grant","planned":false,"acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The RSUs were awarded and granted to Mr. Thornton for services performed."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest on the third anniversary of the grant date, or upon change of control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest on the third anniversary of the grant date, or upon change of control."}],"balance_after":32191,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001683168-25-004664","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316825004664/ownership.xml","form_type":"4"}},{"id":1104747,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31183,"kind":"person","name":"Dal Poggetto John","position":1,"cik":"0001791040","reported_name":"Dal Poggetto John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller"}}],"security":"Restricted Stock Units","published_at":"2025-06-20T21:00:08.000Z","date":"2025-06-19","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The RSUs were awarded and granted to Mr. Dal Poggetto for services performed."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest on the third anniversary of the grant date, or upon change of control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest on the third anniversary of the grant date, or upon change of control."}],"balance_after":20250,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001683168-25-004663","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316825004663/ownership.xml","form_type":"4"}},{"id":1104745,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31184,"kind":"person","name":"DVONCH JEROME J","position":1,"cik":"0001518735","reported_name":"DVONCH JEROME J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-06-20T21:00:05.000Z","date":"2025-06-19","kind":"grant","planned":false,"acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The RSUs were awarded and granted to Mr. Dvonch for services performed."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs on the third anniversary of the grant date, or upon change of control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs on the third anniversary of the grant date, or upon change of control."}],"balance_after":25515,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001683168-25-004662","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316825004662/ownership.xml","form_type":"4"}},{"id":1104744,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31186,"kind":"person","name":"Trombly Amy Moss","position":1,"cik":"0001384640","reported_name":"Trombly Amy Moss","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-06-20T21:00:03.000Z","date":"2025-06-19","kind":"grant","planned":false,"acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The RSUs were awarded and granted to Ms. Trombly for services performed."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest on the third anniversary of the grant date, or upon change of control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest on the third anniversary of the grant date, or upon change of control."}],"balance_after":32185,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001683168-25-004661","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316825004661/ownership.xml","form_type":"4"}},{"id":1313893,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":78266,"kind":"person","name":"Thornton Bruce","position":1,"cik":"0001383288","reported_name":"Thornton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP & COO"}}],"security":"Restricted Stock Units","published_at":"2025-01-03T22:02:11.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The RSUs were awarded and granted to Mr. Thornton for services performed as part of the Company's annual equity grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest one-third each on July 2, 2025, July 2, 2026 and January 2, 2027, or upon change of control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest one-third each on July 2, 2025, July 2, 2026 and January 2, 2027, or upon change of control."}],"balance_after":18691,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001683168-25-000084","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316825000084/ownership.xml","form_type":"4"}},{"id":1313892,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":70572,"kind":"person","name":"Birnbaum Jay E","position":1,"cik":"0001397470","reported_name":"Birnbaum Jay E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-01-03T22:02:10.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. Birnbaum for services performed on the Board of Directors as part of the Company's annual grant of stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest one third each on 1/2/2026, 1/2/2027 and 1/2/2028, or upon change of control."}],"balance_after":10029,"derivative":{"exercise_price":2.68,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001683168-25-000083","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316825000083/ownership.xml","form_type":"4"}},{"id":1314010,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31191,"kind":"person","name":"MCLAUGHLIN JOHN","position":1,"cik":"0001203240","reported_name":"MCLAUGHLIN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-01-03T22:02:08.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. McLaughlin for services performed on the Board of Directors as part of the Company's annual grant of stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest one third each on 1/2/2026, 1/2/2027 and 1/2/2028, or upon change of control."}],"balance_after":10044,"derivative":{"exercise_price":2.68,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001683168-25-000082","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203240/000168316825000082/ownership.xml","form_type":"4"}},{"id":1313890,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31186,"kind":"person","name":"Trombly Amy Moss","position":1,"cik":"0001384640","reported_name":"Trombly Amy Moss","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-01-03T22:02:07.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The RSUs were awarded and granted to Ms. Trombly for services performed as part of the Company's annual equity grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest one-third each on July 2, 2025, July 2, 2026 and January 2, 2027, or upon change of control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest one-third each on July 2, 2025, July 2, 2026 and January 2, 2027, or upon change of control."}],"balance_after":18685,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001683168-25-000081","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316825000081/ownership.xml","form_type":"4"}},{"id":1314961,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31222,"kind":"person","name":"Weigerstorfer Philippe","position":1,"cik":"0001751449","reported_name":"Weigerstorfer Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-01-03T22:02:06.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. Weigerstorfer for services performed on the Board of Directors as part of the Company's annual grant of stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest one third each on 1/2/2026, 1/2/2027 and 1/2/2028, or upon change of control."}],"balance_after":10001,"derivative":{"exercise_price":2.68,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001683168-25-000080","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751449/000168316825000080/ownership.xml","form_type":"4"}},{"id":1313891,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31184,"kind":"person","name":"DVONCH JEROME J","position":1,"cik":"0001518735","reported_name":"DVONCH JEROME J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-01-03T22:02:05.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The RSUs were awarded and granted to Mr. Dvonch for services performed as part of the Company's annual equity grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest one-third each on July 2, 2025, July 2, 2026 and January 2, 2027, or upon change of control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest one-third each on July 2, 2025, July 2, 2026 and January 2, 2027, or upon change of control."}],"balance_after":15891,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001683168-25-000079","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316825000079/ownership.xml","form_type":"4"}},{"id":1313889,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31183,"kind":"person","name":"Dal Poggetto John","position":1,"cik":"0001791040","reported_name":"Dal Poggetto John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller"}}],"security":"Restricted Stock Units","published_at":"2025-01-03T22:02:03.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The RSUs were awarded and granted to Mr. Dal Poggetto for services performed as part of the Company's annual equity grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest one-third each on July 2, 2025, July 2, 2026 and January 2, 2027, or upon change of control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest one-third each on July 2, 2025, July 2, 2026 and January 2, 2027, or upon change of control."}],"balance_after":10250,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001683168-25-000078","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316825000078/ownership.xml","form_type":"4"}},{"id":1471807,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31186,"kind":"person","name":"Trombly Amy Moss","position":1,"cik":"0001384640","reported_name":"Trombly Amy Moss","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-06-21T21:06:10.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":53586,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were awarded and granted as Restricted Stock Units to Ms. Trombly for services performed as part of the Company's annual bonus compensation to executives. The shares vested in full on the grant date."}],"balance_after":153586,"source":{"system":"sec-edgar","filing":"0001683168-24-004426","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316824004426/ownership.xml","form_type":"4"}},{"id":1471808,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":78266,"kind":"person","name":"Thornton Bruce","position":1,"cik":"0001383288","reported_name":"Thornton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-06-21T21:05:57.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":53586,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were awarded and granted as Restricted Stock Units to Mr. Thornton for services performed as part of the Company's annual bonus compensation to executives. The shares vested in full on the grant date."}],"balance_after":154411,"source":{"system":"sec-edgar","filing":"0001683168-24-004425","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316824004425/ownership.xml","form_type":"4"}},{"id":1471806,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31184,"kind":"person","name":"DVONCH JEROME J","position":1,"cik":"0001518735","reported_name":"DVONCH JEROME J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-06-21T21:05:40.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":53586,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were awarded and granted as Restricted Stock Units to Mr. Dvonch for services performed as part of the Company's annual bonus compensation to executives. The shares vested in full on the grant date."}],"balance_after":84595,"source":{"system":"sec-edgar","filing":"0001683168-24-004424","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316824004424/ownership.xml","form_type":"4"}},{"id":1471805,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31183,"kind":"person","name":"Dal Poggetto John","position":1,"cik":"0001791040","reported_name":"Dal Poggetto John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller"}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-06-21T21:05:23.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were awarded and granted as Restricted Stock Units to Mr. Dal Poggetto for services performed as part of the Company's annual bonus compensation to executives. The shares vested in full on the grant date."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001683168-24-004423","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316824004423/ownership.xml","form_type":"4"}},{"id":1697790,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31186,"kind":"person","name":"Trombly Amy Moss","position":1,"cik":"0001384640","reported_name":"Trombly Amy Moss","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2023-12-29T22:26:33.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Ms. Trombly for services performed as part of the Company's annual grant of stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest one third each on 12/29/2024, 12/29/2025 and 12/29/2026, or upon change of control or as provided by Ms. Trombly's employment agreement."}],"balance_after":173648,"derivative":{"exercise_price":0.18,"expiration_date":"2033-12-29","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001683168-23-009158","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316823009158/ownership.xml","form_type":"4"}},{"id":1697789,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":78266,"kind":"person","name":"Thornton Bruce","position":1,"cik":"0001383288","reported_name":"Thornton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP & COO"}}],"security":"Stock option (right to buy)","published_at":"2023-12-29T22:25:56.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. Thornton for services performed as part of the Company's annual grant of stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest one third each on 12/29/2024, 12/29/2025 and 12/29/2026, or upon change of control or as provided by Mr. Thornton's employment agreement."}],"balance_after":176781,"derivative":{"exercise_price":0.18,"expiration_date":"2033-12-29","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001683168-23-009156","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316823009156/ownership.xml","form_type":"4"}},{"id":1697788,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31183,"kind":"person","name":"Dal Poggetto John","position":1,"cik":"0001791040","reported_name":"Dal Poggetto John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller"}}],"security":"Stock option (right to buy)","published_at":"2023-12-29T22:25:13.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were awarded and granted to Mr. Dal Poggetto for services performed as part of the Company's annual grant of stock options."}],"balance_after":55000,"derivative":{"exercise_price":0.18,"exercise_date":"2023-12-29","expiration_date":"2033-12-29","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001683168-23-009154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316823009154/ownership.xml","form_type":"4"}},{"id":1697787,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31184,"kind":"person","name":"DVONCH JEROME J","position":1,"cik":"0001518735","reported_name":"DVONCH JEROME J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Stock option (right to buy)","published_at":"2023-12-29T22:24:22.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. Dvonch for services performed as part of the Company's annual grant of stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest one third each on 12/29/2024, 12/29/2025 and 12/29/2026, or upon change of control."}],"balance_after":117777,"derivative":{"exercise_price":0.18,"expiration_date":"2033-12-29","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001683168-23-009152","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316823009152/ownership.xml","form_type":"4"}},{"id":1839386,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31186,"kind":"person","name":"Trombly Amy Moss","position":1,"cik":"0001384640","reported_name":"Trombly Amy Moss","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2023-07-03T21:00:15.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were awarded and granted to Ms. Trombly for services performed as part of the Company's annual bonus compensation to executives."}],"balance_after":213648,"source":{"system":"sec-edgar","filing":"0001683168-23-004632","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316823004632/ownership.xml","form_type":"4"}},{"id":1839385,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":78266,"kind":"person","name":"Thornton Bruce","position":1,"cik":"0001383288","reported_name":"Thornton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock, $0.0001 par value","published_at":"2023-07-03T21:00:13.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were awarded and granted to Mr. Thornton for services performed as part of the Company's annual bonus compensation to executives."}],"balance_after":216781,"source":{"system":"sec-edgar","filing":"0001683168-23-004631","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316823004631/ownership.xml","form_type":"4"}},{"id":2074104,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":121215,"kind":"person","name":"White Chad Norman","position":1,"cik":"0001949607","reported_name":"White Chad Norman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2022-12-30T22:02:55.000Z","date":"2022-12-29","kind":"grant","acquired":true,"shares":9753,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. White for services performed as part of the Company's annual grant of stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest one third each on 12/29/2023, 12/29/2024 and 12/29/2025, or upon change of control."}],"balance_after":14753,"derivative":{"exercise_price":1.08,"expiration_date":"2032-12-29","underlying":"Common Stock","underlying_shares":9753},"source":{"system":"sec-edgar","filing":"0001683168-22-008722","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316822008722/ownership.xml","form_type":"4"}},{"id":2074331,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31222,"kind":"person","name":"Weigerstorfer Philippe","position":1,"cik":"0001751449","reported_name":"Weigerstorfer Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-12-30T22:02:19.000Z","date":"2022-12-29","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. Weigerstorfer for services performed on the Board of Directors as part of the Company's annual grant of stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest one third each on 12/29/2023, 12/29/2024 and 12/29/2025, or upon change of control."}],"balance_after":50000,"derivative":{"exercise_price":1.08,"expiration_date":"2032-12-29","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001683168-22-008721","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751449/000168316822008721/ownership.xml","form_type":"4"}},{"id":2074103,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31186,"kind":"person","name":"Trombly Amy Moss","position":1,"cik":"0001384640","reported_name":"Trombly Amy Moss","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2022-12-30T22:01:57.000Z","date":"2022-12-29","kind":"grant","acquired":true,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Ms. Trombly for services performed as part of the Company's annual grant of stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest one third each on 12/29/2023, 12/29/2024 and 12/29/2025, or upon change of control or as provided by Ms. Trombly's employment agreement."}],"balance_after":113648,"derivative":{"exercise_price":1.08,"expiration_date":"2032-12-29","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001683168-22-008720","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316822008720/ownership.xml","form_type":"4"}},{"id":2074096,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":78266,"kind":"person","name":"Thornton Bruce","position":1,"cik":"0001383288","reported_name":"Thornton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock option (right to buy)","published_at":"2022-12-30T22:01:33.000Z","date":"2022-12-29","kind":"grant","acquired":true,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. Thornton for services performed as part of the Company's annual grant of stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest one third each on 12/29/2023, 12/29/2024 and 12/29/2025, or upon change of control or as provided by Mr. Thornton's employment agreement."}],"balance_after":116781,"derivative":{"exercise_price":1.08,"expiration_date":"2032-12-29","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001683168-22-008719","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316822008719/ownership.xml","form_type":"4"}},{"id":2074123,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31191,"kind":"person","name":"MCLAUGHLIN JOHN","position":1,"cik":"0001203240","reported_name":"MCLAUGHLIN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-12-30T22:01:13.000Z","date":"2022-12-29","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. McLaughlin for services performed on the Board of Directors as part of the Company's annual grant of stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest one third each on 12/29/2023, 12/29/2024 and 12/29/2025, or upon change of control."}],"balance_after":53252,"derivative":{"exercise_price":1.08,"expiration_date":"2032-12-29","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001683168-22-008718","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203240/000168316822008718/ownership.xml","form_type":"4"}},{"id":2074092,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":70572,"kind":"person","name":"Birnbaum Jay E","position":1,"cik":"0001397470","reported_name":"Birnbaum Jay E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-12-30T22:00:51.000Z","date":"2022-12-29","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. Birnbaum for services performed on the Board of Directors as part of the Company's annual grant of stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest one third each on 12/29/2023, 12/29/2024 and 12/29/2025, or upon change of control."}],"balance_after":52904,"derivative":{"exercise_price":1.08,"expiration_date":"2032-12-29","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001683168-22-008717","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316822008717/ownership.xml","form_type":"4"}},{"id":2435000,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31222,"kind":"person","name":"Weigerstorfer Philippe","position":1,"cik":"0001751449","reported_name":"Weigerstorfer Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-01-15T01:34:09.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. Weigerstorfer for services performed on the Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 10,000 each on 07/14/2022, 07/14/2023 and 07/14/2024, or upon change of control."}],"balance_after":30000,"derivative":{"exercise_price":4.6,"expiration_date":"2032-01-14","underlying":"Common stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001683168-22-000280","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751449/000168316822000280/ownership.xml","form_type":"4"}},{"id":2434692,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31186,"kind":"person","name":"Trombly Amy Moss","position":1,"cik":"0001384640","reported_name":"Trombly Amy Moss","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2022-01-15T01:33:46.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Ms. Trombly for services performed."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 10,000 each on 07/14/2022, 07/14/2023 and 07/14/2024, or upon change of control."}],"balance_after":73648,"derivative":{"exercise_price":4.6,"expiration_date":"2032-01-14","underlying":"Common stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001683168-22-000279","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316822000279/ownership.xml","form_type":"4"}},{"id":2434693,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":78266,"kind":"person","name":"Thornton Bruce","position":1,"cik":"0001383288","reported_name":"Thornton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Stock option (right to buy)","published_at":"2022-01-15T01:33:04.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. Thornton for services performed."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 10,000 each on 07/14/2022, 07/14/2023 and 07/14/2024, or upon change of control."}],"balance_after":76781,"derivative":{"exercise_price":4.6,"expiration_date":"2032-01-14","underlying":"Common stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001683168-22-000278","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316822000278/ownership.xml","form_type":"4"}},{"id":2434712,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31191,"kind":"person","name":"MCLAUGHLIN JOHN","position":1,"cik":"0001203240","reported_name":"MCLAUGHLIN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-01-15T01:32:39.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. McLaughlin for services performed on the Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 10,000 each on 07/14/2022, 07/14/2023 and 07/14/2024, or upon change of control."}],"balance_after":33252,"derivative":{"exercise_price":4.6,"expiration_date":"2032-01-14","underlying":"Common stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001683168-22-000277","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203240/000168316822000277/ownership.xml","form_type":"4"}},{"id":2434691,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31184,"kind":"person","name":"DVONCH JEROME J","position":1,"cik":"0001518735","reported_name":"DVONCH JEROME J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2022-01-15T01:32:13.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. Dvonch for services performed."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 10,000 options each on 07/14/2022, 07/14/2023, 07/14/2024 and or upon a change of control."}],"balance_after":57777,"derivative":{"exercise_price":4.6,"expiration_date":"2032-01-14","underlying":"Common stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001683168-22-000276","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316822000276/ownership.xml","form_type":"4"}},{"id":2434690,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":70572,"kind":"person","name":"Birnbaum Jay E","position":1,"cik":"0001397470","reported_name":"Birnbaum Jay E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-01-15T01:31:43.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. Birnbaum for services performed on the Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 10,000 each on 07/14/2022, 07/14/2023 and 07/14/2024, or upon change of control."}],"balance_after":32904,"derivative":{"exercise_price":4.6,"expiration_date":"2032-01-14","underlying":"Common stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001683168-22-000275","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316822000275/ownership.xml","form_type":"4"}},{"id":2908007,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":78266,"kind":"person","name":"Thornton Bruce","position":1,"cik":"0001383288","reported_name":"Thornton Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO"}}],"security":"Stock option (right to buy)","published_at":"2021-01-13T21:50:53.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":27777,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. Thornton for services performed."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest one third each on 01/07/2022, 01/07/2023 and 01/07/2024 or upon change of control."}],"balance_after":47377,"derivative":{"exercise_price":8.03,"expiration_date":"2031-01-07","underlying":"Common Stock","underlying_shares":27777},"source":{"system":"sec-edgar","filing":"0001683168-21-000129","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316821000129/ownership.xml","form_type":"4"}},{"id":2912000,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31184,"kind":"person","name":"DVONCH JEROME J","position":1,"cik":"0001518735","reported_name":"DVONCH JEROME J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2021-01-08T21:16:57.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":27777,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. Dvonch for services performed."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest one third each on 01/07/2022, 01/07/2023 and 01/07/2024, or upon a change of control."}],"balance_after":27777,"derivative":{"exercise_price":8.03,"expiration_date":"2031-01-07","underlying":"Common Stock","underlying_shares":27777},"source":{"system":"sec-edgar","filing":"0001683168-21-000066","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316821000066/ownership.xml","form_type":"4"}},{"id":2912001,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31186,"kind":"person","name":"Trombly Amy Moss","position":1,"cik":"0001384640","reported_name":"Trombly Amy Moss","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2021-01-08T21:16:39.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":27777,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Ms. Trombly for services performed."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest one third each on 01/07/2022, 01/07/2023 and 01/07/2024, or upon change of control."}],"balance_after":43648,"derivative":{"exercise_price":8.03,"expiration_date":"2031-01-07","underlying":"Common Stock","underlying_shares":27777},"source":{"system":"sec-edgar","filing":"0001683168-21-000065","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316821000065/ownership.xml","form_type":"4"}},{"id":3170028,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31183,"kind":"person","name":"Dal Poggetto John","position":1,"cik":"0001791040","reported_name":"Dal Poggetto John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-04-24T20:15:55.000Z","date":"2020-04-23","kind":"grant","acquired":true,"shares":3086,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were granted pursuant to the mutual separation and release agreement dated April 14, 2020."}],"balance_after":3201,"source":{"system":"sec-edgar","filing":"0001683168-20-001272","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316820001272/ownership.xml","form_type":"4"}},{"id":3170266,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":149670,"kind":"person","name":"Edwards Robert Grant","position":1,"cik":"0001810327","reported_name":"Edwards Robert Grant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-04-24T16:17:14.000Z","date":"2020-04-23","kind":"grant","acquired":true,"shares":2609,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The award will vest in three years, with the first third vesting on April 14, 2021, second third will vest on April 14, 2022 and remaining third will vest on April 14, 2023. If the Issuer terminates Mr. Edwards prior to April 14, 2021, all stock will vest immediately on the termination date. If the Issuer terminates Mr. Edwards on or after April 14, 2021, including by not renewing this agreement, all unvested stock will be forfeited. If Mr. Edwards terminates, all unvested stock will be forfeited."}],"balance_after":2609,"source":{"system":"sec-edgar","filing":"0001683168-20-001273","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810327/000168316820001273/ownership.xml","form_type":"4"}},{"id":3321923,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31186,"kind":"person","name":"Trombly Amy Moss","position":1,"cik":"0001384640","reported_name":"Trombly Amy Moss","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2020-01-03T22:03:48.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":2380,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Ms. Trombly for services performed."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest in two equal tranches: the first half vest on 7/2/2020 and the remaining half vest on 1/2/2021."}],"balance_after":15871,"derivative":{"exercise_price":4.55,"expiration_date":"2021-01-02","underlying":"Common Stock","underlying_shares":2380},"source":{"system":"sec-edgar","filing":"0001683168-20-000020","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316820000020/ownership.xml","form_type":"4"}},{"id":3321922,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31186,"kind":"person","name":"Trombly Amy Moss","position":1,"cik":"0001384640","reported_name":"Trombly Amy Moss","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2020-01-03T22:03:48.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":13491,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Ms. Trombly for services performed."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in two equal tranches: the first half vest on 7/1/2020 and the remaining half vest on 12/31/2020."}],"balance_after":13491,"derivative":{"exercise_price":4.36,"expiration_date":"2019-12-31","underlying":"Common stock","underlying_shares":13491},"source":{"system":"sec-edgar","filing":"0001683168-20-000020","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316820000020/ownership.xml","form_type":"4"}},{"id":3321921,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31183,"kind":"person","name":"Dal Poggetto John","position":1,"cik":"0001791040","reported_name":"Dal Poggetto John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2020-01-03T22:02:46.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":13000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were awarded and granted to Mr. Dal Poggetto for services performed."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in two equal tranches: the first half vest on 7/1/2020 and the remaining half vest on 12/31/2020."}],"balance_after":18496,"derivative":{"exercise_price":4.36,"expiration_date":"2029-12-31","underlying":"Common stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001683168-20-000019","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316820000019/ownership.xml","form_type":"4"}},{"id":3695413,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161029,"kind":"person","name":"Schutz James J","position":1,"cik":"0001367079","reported_name":"Schutz James J","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CEO and Former Director"}}],"security":"Stock option (right to buy)","published_at":"2019-01-16T00:17:22.000Z","date":"2019-01-14","kind":"other","acquired":false,"shares":67733,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The stock options were originally granted on July 20, 2018 as a bonus for fiscal year 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options expired on January 14, 2019 in connection with the Separation and Mutual Release Agreement between the Issuer and Mr. Schutz, dated December 13, 2018."}],"balance_after":0,"derivative":{"exercise_price":2.41,"expiration_date":"2019-01-14","underlying":"Common Stock","underlying_shares":67733},"source":{"system":"sec-edgar","filing":"0001683168-19-000118","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316819000118/ownership.xml","form_type":"4"}},{"id":3695412,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161029,"kind":"person","name":"Schutz James J","position":1,"cik":"0001367079","reported_name":"Schutz James J","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CEO and Former Director"}}],"security":"Stock option (right to buy)","published_at":"2019-01-16T00:17:22.000Z","date":"2019-01-14","kind":"other","acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The stock options were originally granted on April 3, 2017 in connection with his services as the Issuer's CEO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options expired on January 14, 2019 in connection with the Separation and Mutual Release Agreement between the Issuer and Mr. Schutz, dated December 13, 2018."}],"balance_after":67733,"derivative":{"exercise_price":7.06,"expiration_date":"2019-01-14","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001683168-19-000118","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316819000118/ownership.xml","form_type":"4"}},{"id":3695411,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161029,"kind":"person","name":"Schutz James J","position":1,"cik":"0001367079","reported_name":"Schutz James J","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CEO and Former Director"}}],"security":"Stock option (right to buy)","published_at":"2019-01-16T00:17:22.000Z","date":"2019-01-14","kind":"other","acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The stock options were originally granted on November 30, 2016 as a signing bonus for his employment agreement, dated July 26, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options expired on January 14, 2019 in connection with the Separation and Mutual Release Agreement between the Issuer and Mr. Schutz, dated December 13, 2018."}],"balance_after":97733,"derivative":{"exercise_price":4.81,"expiration_date":"2019-01-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001683168-19-000118","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316819000118/ownership.xml","form_type":"4"}},{"id":3695410,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161029,"kind":"person","name":"Schutz James J","position":1,"cik":"0001367079","reported_name":"Schutz James J","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CEO and Former Director"}}],"security":"Stock option (right to buy)","published_at":"2019-01-16T00:17:22.000Z","date":"2019-01-14","kind":"other","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The stock options were originally granted on September 19, 2013 pursuant to the Issuer's entry into a new employment agreement with him, effective June 02, 2013."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options expired on January 14, 2019 in connection with the Separation and Mutual Release Agreement between the Issuer and Mr. Schutz, dated December 13, 2018."}],"balance_after":147733,"derivative":{"exercise_price":30,"expiration_date":"2019-01-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001683168-19-000118","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316819000118/ownership.xml","form_type":"4"}},{"id":3695409,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161029,"kind":"person","name":"Schutz James J","position":1,"cik":"0001367079","reported_name":"Schutz James J","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CEO and Former Director"}}],"security":"Stock option (right to buy)","published_at":"2019-01-16T00:17:22.000Z","date":"2019-01-14","kind":"other","acquired":false,"shares":4285,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The stock options were originally granted on August 24, 2012 pursuant to the Issuer's 2012 Bonus Plan in lieu of cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options expired on January 14, 2019 in connection with the Separation and Mutual Release Agreement between the Issuer and Mr. Schutz, dated December 13, 2018."}],"balance_after":167733,"derivative":{"exercise_price":32.55,"expiration_date":"2019-01-14","underlying":"Common Stock","underlying_shares":4285},"source":{"system":"sec-edgar","filing":"0001683168-19-000118","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316819000118/ownership.xml","form_type":"4"}},{"id":3695408,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161029,"kind":"person","name":"Schutz James J","position":1,"cik":"0001367079","reported_name":"Schutz James J","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CEO and Former Director"}}],"security":"Stock option (right to buy)","published_at":"2019-01-16T00:17:22.000Z","date":"2019-01-14","kind":"other","acquired":false,"shares":5357,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The stock options were originally granted on March 7, 2012 pursuant to the Issuer's 2011 Bonus Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options expired on January 14, 2019 in connection with the Separation and Mutual Release Agreement between the Issuer and Mr. Schutz, dated December 13, 2018."}],"balance_after":172018,"derivative":{"exercise_price":43.75,"expiration_date":"2019-01-14","underlying":"Common Stock","underlying_shares":5357},"source":{"system":"sec-edgar","filing":"0001683168-19-000118","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316819000118/ownership.xml","form_type":"4"}},{"id":3695407,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161029,"kind":"person","name":"Schutz James J","position":1,"cik":"0001367079","reported_name":"Schutz James J","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CEO and Former Director"}}],"security":"Stock option (right to buy)","published_at":"2019-01-16T00:17:22.000Z","date":"2019-01-14","kind":"other","acquired":false,"shares":1428,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The stock options were originally granted on June 16, 2011 pursuant to the Issuer's 2011 Bonus Plan in lieu of cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options expired on January 14, 2019 in connection with the Separation and Mutual Release Agreement between the Issuer and Mr. Schutz, dated December 13, 2018."}],"balance_after":177375,"derivative":{"exercise_price":56,"expiration_date":"2019-01-14","underlying":"Common Stock","underlying_shares":1428},"source":{"system":"sec-edgar","filing":"0001683168-19-000118","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316819000118/ownership.xml","form_type":"4"}},{"id":3695406,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161029,"kind":"person","name":"Schutz James J","position":1,"cik":"0001367079","reported_name":"Schutz James J","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CEO and Former Director"}}],"security":"Stock option (right to buy)","published_at":"2019-01-16T00:17:22.000Z","date":"2019-01-14","kind":"other","acquired":false,"shares":3928,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The stock options were originally granted on March 31, 2011 pursuant to the Issuer's 2010 Bonus Plan in lieu of cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options expired on January 14, 2019 in connection with the Separation and Mutual Release Agreement between the Issuer and Mr. Schutz, dated December 13, 2018."}],"balance_after":178803,"derivative":{"exercise_price":70.35,"expiration_date":"2019-01-14","underlying":"Common Stock","underlying_shares":3928},"source":{"system":"sec-edgar","filing":"0001683168-19-000118","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316819000118/ownership.xml","form_type":"4"}},{"id":3695405,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161029,"kind":"person","name":"Schutz James J","position":1,"cik":"0001367079","reported_name":"Schutz James J","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CEO and Former Director"}}],"security":"Stock option (right to buy)","published_at":"2019-01-16T00:17:22.000Z","date":"2019-01-14","kind":"other","acquired":false,"shares":1785,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The stock options were originally granted on June 7, 2010 pursuant to the Issuer's 2010 Bonus Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options expired on January 14, 2019 in connection with the Separation and Mutual Release Agreement between the Issuer and Mr. Schutz, dated December 13, 2018."}],"balance_after":182731,"derivative":{"exercise_price":68.95,"expiration_date":"2019-01-14","underlying":"Common Stock","underlying_shares":1785},"source":{"system":"sec-edgar","filing":"0001683168-19-000118","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316819000118/ownership.xml","form_type":"4"}},{"id":3695404,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161029,"kind":"person","name":"Schutz James J","position":1,"cik":"0001367079","reported_name":"Schutz James J","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CEO and Former Director"}}],"security":"Stock option (right to buy)","published_at":"2019-01-16T00:17:22.000Z","date":"2019-01-14","kind":"other","acquired":false,"shares":3571,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The stock options were originally granted on February 10, 2010."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options expired on January 14, 2019 in connection with the Separation and Mutual Release Agreement between the Issuer and Mr. Schutz, dated December 13, 2018."}],"balance_after":184516,"derivative":{"exercise_price":66.85,"expiration_date":"2019-01-14","underlying":"Common Stock","underlying_shares":3571},"source":{"system":"sec-edgar","filing":"0001683168-19-000118","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316819000118/ownership.xml","form_type":"4"}},{"id":3695403,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161029,"kind":"person","name":"Schutz James J","position":1,"cik":"0001367079","reported_name":"Schutz James J","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CEO and Former Director"}}],"security":"Stock option (right to buy)","published_at":"2019-01-16T00:17:22.000Z","date":"2019-01-14","kind":"other","acquired":false,"shares":5271,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock options were originally granted on March 10, 2009."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options expired on January 14, 2019 in connection with the Separation and Mutual Release Agreement between the Issuer and Mr. Schutz, dated December 13, 2018."}],"balance_after":188087,"derivative":{"exercise_price":38.15,"expiration_date":"2019-01-14","underlying":"Common Stock","underlying_shares":5271},"source":{"system":"sec-edgar","filing":"0001683168-19-000118","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316819000118/ownership.xml","form_type":"4"}},{"id":3695400,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161028,"kind":"person","name":"Miller Robert E","position":1,"cik":"0001367082","reported_name":"Miller Robert E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CFO"}}],"security":"Stock option (right to buy)","published_at":"2019-01-16T00:16:36.000Z","date":"2019-01-14","kind":"other","acquired":false,"shares":67733,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"The stock options were originally granted on July 20, 2018 as a bonus for fiscal year 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options expired on January 14, 2019 in connection with the Separation and Mutual Release Agreement between the Issuer and Mr. Miller, dated December 13, 2018."}],"balance_after":0,"derivative":{"exercise_price":2.41,"expiration_date":"2019-01-14","underlying":"Common Stock","underlying_shares":67733},"source":{"system":"sec-edgar","filing":"0001683168-19-000117","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316819000117/ownership.xml","form_type":"4"}},{"id":3695399,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161028,"kind":"person","name":"Miller Robert E","position":1,"cik":"0001367082","reported_name":"Miller Robert E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CFO"}}],"security":"Stock option (right to buy)","published_at":"2019-01-16T00:16:36.000Z","date":"2019-01-14","kind":"other","acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The stock options were originally granted on April 3, 2017 in connection with his service as the Issuer's CFO."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options expired on January 14, 2019 in connection with the Separation and Mutual Release Agreement between the Issuer and Mr. Miller, dated December 13, 2018."}],"balance_after":67733,"derivative":{"exercise_price":7.06,"expiration_date":"2019-01-14","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001683168-19-000117","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316819000117/ownership.xml","form_type":"4"}},{"id":3695398,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161028,"kind":"person","name":"Miller Robert E","position":1,"cik":"0001367082","reported_name":"Miller Robert E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CFO"}}],"security":"Stock option (right to buy)","published_at":"2019-01-16T00:16:36.000Z","date":"2019-01-14","kind":"other","acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The stock options were originally granted on November 30, 2016 as a signing bonus for his employment agreement, dated November 30, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options expired on January 14, 2019 in connection with the Separation and Mutual Release Agreement between the Issuer and Mr. Miller, dated December 13, 2018."}],"balance_after":97733,"derivative":{"exercise_price":4.81,"expiration_date":"2019-01-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001683168-19-000117","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316819000117/ownership.xml","form_type":"4"}},{"id":3695397,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161028,"kind":"person","name":"Miller Robert E","position":1,"cik":"0001367082","reported_name":"Miller Robert E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CFO"}}],"security":"Stock option (right to buy)","published_at":"2019-01-16T00:16:36.000Z","date":"2019-01-14","kind":"other","acquired":false,"shares":7912,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The stock options were originally granted on August 21, 2015 for the achievement of target milestones in fiscal year ended March 31, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options expired on January 14, 2019 in connection with the Separation and Mutual Release Agreement between the Issuer and Mr. Miller, dated December 13, 2018."}],"balance_after":147733,"derivative":{"exercise_price":5.8,"expiration_date":"2019-01-14","underlying":"Common Stock","underlying_shares":7912},"source":{"system":"sec-edgar","filing":"0001683168-19-000117","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316819000117/ownership.xml","form_type":"4"}},{"id":3695396,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161028,"kind":"person","name":"Miller Robert E","position":1,"cik":"0001367082","reported_name":"Miller Robert E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CFO"}}],"security":"Stock option (right to buy)","published_at":"2019-01-16T00:16:36.000Z","date":"2019-01-14","kind":"other","acquired":false,"shares":26020,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The stock options were originally granted on March 4, 2014 as compensation in lieu of cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options expired on January 14, 2019 in connection with the Separation and Mutual Release Agreement between the Issuer and Mr. Miller, dated December 13, 2018."}],"balance_after":155645,"derivative":{"exercise_price":19.5,"expiration_date":"2019-01-14","underlying":"Common Stock","underlying_shares":26020},"source":{"system":"sec-edgar","filing":"0001683168-19-000117","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316819000117/ownership.xml","form_type":"4"}},{"id":3695395,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161028,"kind":"person","name":"Miller Robert E","position":1,"cik":"0001367082","reported_name":"Miller Robert E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CFO"}}],"security":"Stock option (right to buy)","published_at":"2019-01-16T00:16:36.000Z","date":"2019-01-14","kind":"other","acquired":false,"shares":5351,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The stock options were originally granted on September 19, 2013 pursuant to the Issuer's 2013 Bonus Plan in lieu of cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options expired on January 14, 2019 in connection with the Separation and Mutual Release Agreement between the Issuer and Mr. Miller, dated December 13, 2018."}],"balance_after":181665,"derivative":{"exercise_price":14.85,"expiration_date":"2019-01-14","underlying":"Common Stock","underlying_shares":5351},"source":{"system":"sec-edgar","filing":"0001683168-19-000117","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316819000117/ownership.xml","form_type":"4"}},{"id":3695394,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161028,"kind":"person","name":"Miller Robert E","position":1,"cik":"0001367082","reported_name":"Miller Robert E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CFO"}}],"security":"Stock option (right to buy)","published_at":"2019-01-16T00:16:36.000Z","date":"2019-01-14","kind":"other","acquired":false,"shares":4285,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The stock options were originally granted on August 24, 2012 pursuant to the Issuer's 2012 Bonus Plan in lieu of cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options expired on January 14, 2019 in connection with the Separation and Mutual Release Agreement between the Issuer and Mr. Miller, dated December 13, 2018."}],"balance_after":187016,"derivative":{"exercise_price":32.55,"expiration_date":"2019-01-14","underlying":"Common Stock","underlying_shares":4285},"source":{"system":"sec-edgar","filing":"0001683168-19-000117","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316819000117/ownership.xml","form_type":"4"}},{"id":3695393,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161028,"kind":"person","name":"Miller Robert E","position":1,"cik":"0001367082","reported_name":"Miller Robert E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CFO"}}],"security":"Stock option (right to buy)","published_at":"2019-01-16T00:16:36.000Z","date":"2019-01-14","kind":"other","acquired":false,"shares":1785,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The stock options were originally granted on March 7, 2012 pursuant to the Issuer's 2011 Bonus Plan in lieu of cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options expired on January 14, 2019 in connection with the Separation and Mutual Release Agreement between the Issuer and Mr. Miller, dated December 13, 2018."}],"balance_after":191301,"derivative":{"exercise_price":43.75,"expiration_date":"2019-01-14","underlying":"Common Stock","underlying_shares":1785},"source":{"system":"sec-edgar","filing":"0001683168-19-000117","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316819000117/ownership.xml","form_type":"4"}},{"id":3695392,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161028,"kind":"person","name":"Miller Robert E","position":1,"cik":"0001367082","reported_name":"Miller Robert E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CFO"}}],"security":"Stock option (right to buy)","published_at":"2019-01-16T00:16:36.000Z","date":"2019-01-14","kind":"other","acquired":false,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The stock options were originally granted on June 16, 2011 pursuant to the Issuer's 2011 Bonus Plan in lieu of cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options expired on January 14, 2019 in connection with the Separation and Mutual Release Agreement between the Issuer and Mr. Miller, dated December 13, 2018."}],"balance_after":193086,"derivative":{"exercise_price":56,"expiration_date":"2019-01-14","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001683168-19-000117","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316819000117/ownership.xml","form_type":"4"}},{"id":3695391,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161028,"kind":"person","name":"Miller Robert E","position":1,"cik":"0001367082","reported_name":"Miller Robert E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CFO"}}],"security":"Stock option (right to buy)","published_at":"2019-01-16T00:16:36.000Z","date":"2019-01-14","kind":"other","acquired":false,"shares":357,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The stock options were originally granted on March 31, 2011 pursuant to the Issuer's 2010 Bonus Plan in lieu of cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options expired on January 14, 2019 in connection with the Separation and Mutual Release Agreement between the Issuer and Mr. Miller, dated December 13, 2018."}],"balance_after":198086,"derivative":{"exercise_price":70.35,"expiration_date":"2019-01-14","underlying":"Common Stock","underlying_shares":357},"source":{"system":"sec-edgar","filing":"0001683168-19-000117","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316819000117/ownership.xml","form_type":"4"}},{"id":3695390,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161028,"kind":"person","name":"Miller Robert E","position":1,"cik":"0001367082","reported_name":"Miller Robert E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CFO"}}],"security":"Stock option (right to buy)","published_at":"2019-01-16T00:16:36.000Z","date":"2019-01-14","kind":"other","acquired":false,"shares":5357,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The stock options were originally granted on June 7, 2010 pursuant to the Issuer's 2010 Bonus Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options expired on January 14, 2019 in connection with the Separation and Mutual Release Agreement between the Issuer and Mr. Miller, dated December 13, 2018."}],"balance_after":198443,"derivative":{"exercise_price":68.95,"expiration_date":"2019-01-14","underlying":"Common Stock","underlying_shares":5357},"source":{"system":"sec-edgar","filing":"0001683168-19-000117","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316819000117/ownership.xml","form_type":"4"}},{"id":3695389,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161028,"kind":"person","name":"Miller Robert E","position":1,"cik":"0001367082","reported_name":"Miller Robert E","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CFO"}}],"security":"Stock option (right to buy)","published_at":"2019-01-16T00:16:36.000Z","date":"2019-01-14","kind":"other","acquired":false,"shares":5271,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The stock options were originally granted on March 10, 2009."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options expired on January 14, 2019 in connection with the Separation and Mutual Release Agreement between the Issuer and Mr. Miller, dated December 13, 2018."}],"balance_after":203800,"derivative":{"exercise_price":38.15,"expiration_date":"2019-01-14","underlying":"Common Stock","underlying_shares":5271},"source":{"system":"sec-edgar","filing":"0001683168-19-000117","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316819000117/ownership.xml","form_type":"4"}},{"id":3697062,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161102,"kind":"person","name":"Sandford Frederick J","position":1,"cik":"0001599691","reported_name":"Sandford Frederick J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Interim CFO"}}],"security":"Stock option (right to buy)","published_at":"2019-01-11T23:17:46.000Z","date":"2019-01-10","kind":"grant","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were granted to Mr. Sandford for his entering into employment with the Issuer as Chief Executive Officer and Interim Chief Financial Officer."}],"balance_after":450000,"derivative":{"exercise_price":0.717,"exercise_date":"2019-07-10","expiration_date":"2029-01-10","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001683168-19-000083","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316819000083/ownership.xml","form_type":"4"}},{"id":3697061,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161102,"kind":"person","name":"Sandford Frederick J","position":1,"cik":"0001599691","reported_name":"Sandford Frederick J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Interim CFO"}}],"security":"Stock option (right to buy)","published_at":"2019-01-11T23:17:46.000Z","date":"2019-01-10","kind":"grant","acquired":true,"shares":400000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were granted to Mr. Sandford as an inducement stock option award in accordance with Nasdaq Listing Rule 5635(c)(4), as an inducement material to his entering into employment with the Issuer as Chief Executive Officer and Interim Chief Financial Officer."}],"balance_after":400000,"derivative":{"exercise_price":0.717,"exercise_date":"2019-07-10","expiration_date":"2029-01-10","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001683168-19-000083","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316819000083/ownership.xml","form_type":"4"}},{"id":3862127,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161029,"kind":"person","name":"Schutz James J","position":1,"cik":"0001367079","reported_name":"Schutz James J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2018-07-24T22:57:41.000Z","date":"2018-07-20","kind":"grant","acquired":true,"shares":67733,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were awarded and granted to Mr. Schutz as a bonus for fiscal year 2018."}],"balance_after":193358,"derivative":{"exercise_price":2.41,"exercise_date":"2018-07-20","expiration_date":"2028-07-20","underlying":"Common Stock","underlying_shares":67733},"source":{"system":"sec-edgar","filing":"0001683168-18-002014","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316818002014/ownership.xml","form_type":"4"}},{"id":3862126,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161028,"kind":"person","name":"Miller Robert E","position":1,"cik":"0001367082","reported_name":"Miller Robert E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2018-07-24T22:54:33.000Z","date":"2018-07-20","kind":"grant","acquired":true,"shares":67733,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The options were awarded and granted to Mr. Miller as a bonus for fiscal year 2018."}],"balance_after":209071,"derivative":{"exercise_price":2.41,"exercise_date":"2018-07-20","expiration_date":"2028-07-20","underlying":"Common Stock","underlying_shares":67733},"source":{"system":"sec-edgar","filing":"0001683168-18-002012","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316818002012/ownership.xml","form_type":"4"}},{"id":3910448,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31191,"kind":"person","name":"MCLAUGHLIN JOHN","position":1,"cik":"0001203240","reported_name":"MCLAUGHLIN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2018-06-02T00:30:54.000Z","date":"2018-05-30","kind":"grant","acquired":true,"shares":1781,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan."}],"balance_after":48728,"source":{"system":"sec-edgar","filing":"0001683168-18-001580","document":"mclaughlin_frm4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203240/000168316818001580/mclaughlin_frm4.xml","form_type":"4"}},{"id":3910369,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":166135,"kind":"person","name":"Harrison Russell Joseph","position":1,"cik":"0001592423","reported_name":"Harrison Russell Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2018-06-02T00:30:27.000Z","date":"2018-05-30","kind":"grant","acquired":true,"shares":1538,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan."}],"balance_after":46520,"source":{"system":"sec-edgar","filing":"0001683168-18-001579","document":"harrison_frm4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316818001579/harrison_frm4.xml","form_type":"4"}},{"id":3910368,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":70572,"kind":"person","name":"Birnbaum Jay E","position":1,"cik":"0001397470","reported_name":"Birnbaum Jay E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2018-06-02T00:28:03.000Z","date":"2018-05-30","kind":"grant","acquired":true,"shares":1052,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan."}],"balance_after":51659,"source":{"system":"sec-edgar","filing":"0001683168-18-001578","document":"birnbaum_frm4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316818001578/birnbaum_frm4.xml","form_type":"4"}},{"id":3996012,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161028,"kind":"person","name":"Miller Robert E","position":1,"cik":"0001367082","reported_name":"Miller Robert E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2018-03-15T01:30:55.000Z","date":"2018-03-13","kind":"purchase","acquired":true,"shares":1200,"price":4.0996,"value":4919.52,"ownership":{"direct":false,"nature":"See Note"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned by Mr. Miller as trustee for The Miller 2005 Grandchildren's Trust, for which Mr. Miller and his wife, Margaret I. Miller, are the trustees."}],"balance_after":18868,"source":{"system":"sec-edgar","filing":"0001683168-18-000672","document":"miller_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316818000672/miller_f4.xml","form_type":"4"}},{"id":3996011,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161028,"kind":"person","name":"Miller Robert E","position":1,"cik":"0001367082","reported_name":"Miller Robert E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2018-03-15T01:30:55.000Z","date":"2018-03-12","kind":"purchase","acquired":true,"shares":1200,"price":4.03,"value":4836.0,"ownership":{"direct":false,"nature":"See Note"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned by Mr. Miller as trustee for The Miller 2005 Grandchildren's Trust, for which Mr. Miller and his wife, Margaret I. Miller, are the trustees."}],"balance_after":17668,"source":{"system":"sec-edgar","filing":"0001683168-18-000672","document":"miller_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316818000672/miller_f4.xml","form_type":"4"}},{"id":3997703,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161028,"kind":"person","name":"Miller Robert E","position":1,"cik":"0001367082","reported_name":"Miller Robert E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par vlue per share","published_at":"2018-03-13T21:42:01.000Z","date":"2018-03-12","kind":"purchase","acquired":true,"shares":1200,"price":4.03,"value":4836.0,"ownership":{"direct":false,"nature":"See Note"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned by Mr. Miller as trustee for The Miller 2005 Grandchildren's Trust, for which Mr. Miller and his wife, Margaret I. Miller, are the trustees."}],"balance_after":16468,"source":{"system":"sec-edgar","filing":"0001683168-18-000658","document":"miller_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316818000658/miller_f4.xml","form_type":"4"}},{"id":3997702,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161028,"kind":"person","name":"Miller Robert E","position":1,"cik":"0001367082","reported_name":"Miller Robert E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par vlue per share","published_at":"2018-03-13T21:42:01.000Z","date":"2018-03-09","kind":"purchase","acquired":true,"shares":1200,"price":3.9,"value":4680.0,"ownership":{"direct":false,"nature":"See Note"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned by Mr. Miller as trustee for The Miller 2005 Grandchildren's Trust, for which Mr. Miller and his wife, Margaret I. Miller, are the trustees."}],"balance_after":15268,"source":{"system":"sec-edgar","filing":"0001683168-18-000658","document":"miller_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316818000658/miller_f4.xml","form_type":"4"}},{"id":4004996,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161029,"kind":"person","name":"Schutz James J","position":1,"cik":"0001367079","reported_name":"Schutz James J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2018-03-09T00:17:56.000Z","date":"2018-03-08","kind":"purchase","acquired":true,"shares":2473,"price":3.99,"value":9867.27,"ownership":{"direct":true},"balance_after":35858,"source":{"system":"sec-edgar","filing":"0001683168-18-000628","document":"schutz_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316818000628/schutz_f4.xml","form_type":"4"}},{"id":4019361,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":70572,"kind":"person","name":"Birnbaum Jay E","position":1,"cik":"0001397470","reported_name":"Birnbaum Jay E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2018-03-03T00:09:31.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":1157,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan."}],"balance_after":50607,"source":{"system":"sec-edgar","filing":"0001683168-18-000573","document":"birnbaum_f4-030118.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316818000573/birnbaum_f4-030118.xml","form_type":"4"}},{"id":4019359,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":166135,"kind":"person","name":"Harrison Russell Joseph","position":1,"cik":"0001592423","reported_name":"Harrison Russell Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2018-03-03T00:04:59.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":1691,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan."}],"balance_after":44982,"source":{"system":"sec-edgar","filing":"0001683168-18-000571","document":"harrison_f4-030118.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316818000571/harrison_f4-030118.xml","form_type":"4"}},{"id":4019475,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31191,"kind":"person","name":"MCLAUGHLIN JOHN","position":1,"cik":"0001203240","reported_name":"MCLAUGHLIN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2018-03-03T00:02:06.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":1958,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan."}],"balance_after":46947,"source":{"system":"sec-edgar","filing":"0001683168-18-000569","document":"mclaughlin_f4-030118.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203240/000168316818000569/mclaughlin_f4-030118.xml","form_type":"4"}},{"id":4019536,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON SURREY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2018-03-02T19:13:43.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":1424,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan."}],"balance_after":43417,"source":{"system":"sec-edgar","filing":"0001683168-18-000575","document":"barbari_f4-030118.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240499/000168316818000575/barbari_f4-030118.xml","form_type":"4"}},{"id":4110703,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161029,"kind":"person","name":"Schutz James J","position":1,"cik":"0001367079","reported_name":"Schutz James J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2018-01-04T02:42:42.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":17211,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as a bonus for services and vests immediately."}],"balance_after":33385,"source":{"system":"sec-edgar","filing":"0001683168-18-000040","document":"schutz_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316818000040/schutz_f4.xml","form_type":"4"}},{"id":4110907,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31191,"kind":"person","name":"MCLAUGHLIN JOHN","position":1,"cik":"0001203240","reported_name":"MCLAUGHLIN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2018-01-04T02:41:58.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":17211,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as a bonus for services and vests immediately."}],"balance_after":44989,"source":{"system":"sec-edgar","filing":"0001683168-18-000039","document":"mclaughlin_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203240/000168316818000039/mclaughlin_f4.xml","form_type":"4"}},{"id":4110702,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":166135,"kind":"person","name":"Harrison Russell Joseph","position":1,"cik":"0001592423","reported_name":"Harrison Russell Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2018-01-04T02:41:06.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":17211,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as a bonus for services and vests immediately."}],"balance_after":43291,"source":{"system":"sec-edgar","filing":"0001683168-18-000038","document":"harrison_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316818000038/harrison_f4.xml","form_type":"4"}},{"id":4110701,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":70572,"kind":"person","name":"Birnbaum Jay E","position":1,"cik":"0001397470","reported_name":"Birnbaum Jay E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2018-01-04T02:40:09.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":25817,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as a bonus for services and vests immediately."}],"balance_after":49450,"source":{"system":"sec-edgar","filing":"0001683168-18-000037","document":"birnbaum_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316818000037/birnbaum_f4.xml","form_type":"4"}},{"id":4111007,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":71545,"kind":"person","name":"BARBARI SHARON","position":1,"cik":"0001240499","reported_name":"BARBARI SHARON SURREY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2018-01-03T21:39:26.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":17211,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as a bonus for services and vests immediately."}],"balance_after":41993,"source":{"system":"sec-edgar","filing":"0001683168-18-000036","document":"barbari_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1240499/000168316818000036/barbari_f4.xml","form_type":"4"}},{"id":4143981,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":161029,"kind":"person","name":"Schutz James J","position":1,"cik":"0001367079","reported_name":"Schutz James J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2017-12-04T21:03:38.000Z","date":"2017-11-30","kind":"purchase","acquired":true,"shares":345,"price":4.95,"value":1707.75,"ownership":{"direct":true},"balance_after":16174,"source":{"system":"sec-edgar","filing":"0001683168-17-003218","document":"schutz_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316817003218/schutz_f4.xml","form_type":"4"}},{"id":4145908,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":31191,"kind":"person","name":"MCLAUGHLIN JOHN","position":1,"cik":"0001203240","reported_name":"MCLAUGHLIN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2017-12-01T21:41:06.000Z","date":"2017-11-29","kind":"grant","acquired":true,"shares":14317,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as a quarterly retainer as well as an annual grant pursuant to the Non-Employee Director Compensation Plan."}],"balance_after":27778,"source":{"system":"sec-edgar","filing":"0001683168-17-003206","document":"mclaughlin_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1203240/000168316817003206/mclaughlin_f4.xml","form_type":"4"}},{"id":4145854,"issuer":{"id":8177,"kind":"organization","name":"Sonoma Pharmaceuticals, Inc."},"owners":[{"id":166135,"kind":"person","name":"Harrison Russell Joseph","position":1,"cik":"0001592423","reported_name":"Harrison Russell Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value per share","published_at":"2017-12-01T21:40:32.000Z","date":"2017-11-29","kind":"grant","acquired":true,"shares":14130,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock was granted by the Issuer as a quarterly retainer as well as an annual grant pursuant to the Non-Employee Director Compensation Plan."}],"balance_after":26080,"source":{"system":"sec-edgar","filing":"0001683168-17-003205","document":"harrison_f4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316817003205/harrison_f4.xml","form_type":"4"}}],"next_cursor":"2017-12-01T21:40:32.000000Z,4145854"}